188 related articles for article (PubMed ID: 25438767)
1. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
2. Fluorescently labeled substrates for monitoring α1,3-fucosyltransferase IX activity.
Lunau N; Seelhorst K; Kahl S; Tscherch K; Stacke C; Rohn S; Thiem J; Hahn U; Meier C
Chemistry; 2013 Dec; 19(51):17379-90. PubMed ID: 24258785
[TBL] [Abstract][Full Text] [Related]
3. Development of α1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide.
Manabe Y; Kasahara S; Takakura Y; Yang X; Takamatsu S; Kamada Y; Miyoshi E; Yoshidome D; Fukase K
Bioorg Med Chem; 2017 Jun; 25(11):2844-2850. PubMed ID: 28284868
[TBL] [Abstract][Full Text] [Related]
4. Structures of NodZ α1,6-fucosyltransferase in complex with GDP and GDP-fucose.
Brzezinski K; Dauter Z; Jaskolski M
Acta Crystallogr D Biol Crystallogr; 2012 Feb; 68(Pt 2):160-8. PubMed ID: 22281745
[TBL] [Abstract][Full Text] [Related]
5. A sequence motif involved in the donor substrate binding by alpha1,6-fucosyltransferase: the role of the conserved arginine residues.
Takahashi T; Ikeda Y; Tateishi A; Yamaguchi Y; Ishikawa M; Taniguchi N
Glycobiology; 2000 May; 10(5):503-10. PubMed ID: 10764839
[TBL] [Abstract][Full Text] [Related]
6. C-terminal amino acids of Helicobacter pylori alpha1,3/4 fucosyltransferases determine type I and type II transfer.
Ma B; Wang G; Palcic MM; Hazes B; Taylor DE
J Biol Chem; 2003 Jun; 278(24):21893-900. PubMed ID: 12676935
[TBL] [Abstract][Full Text] [Related]
7. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.
Baumgärtner F; Seitz L; Sprenger GA; Albermann C
Microb Cell Fact; 2013 May; 12():40. PubMed ID: 23635327
[TBL] [Abstract][Full Text] [Related]
8. Mechanism and specificity of human alpha-1,3-fucosyltransferase V.
Murray BW; Takayama S; Schultz J; Wong CH
Biochemistry; 1996 Aug; 35(34):11183-95. PubMed ID: 8780523
[TBL] [Abstract][Full Text] [Related]
9. FRET-based direct and continuous monitoring of human fucosyltransferases activity: an efficient synthesis of versatile GDP-L-fucose derivatives from abundant D-galactose.
Maeda T; Nishimura S
Chemistry; 2008; 14(2):478-87. PubMed ID: 17929334
[TBL] [Abstract][Full Text] [Related]
10. Participation of an endogenous inhibitor of fucosyltransferase activities in the developmental regulation of intestinal fucosylation processes.
Ruggiero-Lopez D; Biol MC; Louisot P; Martin A
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):801-6. PubMed ID: 1953674
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides.
Bai J; Wu Z; Sugiarto G; Gadi MR; Yu H; Li Y; Xiao C; Ngo A; Zhao B; Chen X; Guan W
Carbohydr Res; 2019 Jul; 480():1-6. PubMed ID: 31132553
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of the milk oligosaccharide 2'-fucosyllactose using recombinant bacterial enzymes.
Albermann C; Piepersberg W; Wehmeier UF
Carbohydr Res; 2001 Aug; 334(2):97-103. PubMed ID: 11502265
[TBL] [Abstract][Full Text] [Related]
13. Effects of endogenous soluble beta-galactoside binding lectins and protein inhibitor of fucosyltransferase on the enzymes involved in the intestinal fucosylation process.
Ruggiero-Lopez D; Louisot P; Martin A
Biochem Biophys Res Commun; 1992 Jun; 185(2):617-23. PubMed ID: 1610354
[TBL] [Abstract][Full Text] [Related]
14. Strategies for Enhancing Microbial Production of 2'-Fucosyllactose, the Most Abundant Human Milk Oligosaccharide.
Liu Y; Zhu Y; Wang H; Wan L; Zhang W; Mu W
J Agric Food Chem; 2022 Sep; 70(37):11481-11499. PubMed ID: 36094047
[TBL] [Abstract][Full Text] [Related]
15. The biosynthesis of Lewis X in Helicobacter pylori.
Chan NW; Stangier K; Sherburne R; Taylor DE; Zhang Y; Dovichi NJ; Palcic MM
Glycobiology; 1995 Oct; 5(7):683-8. PubMed ID: 8608270
[TBL] [Abstract][Full Text] [Related]
16. Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity.
de Vries T; Srnka CA; Palcic MM; Swiedler SJ; van den Eijnden DH; Macher BA
J Biol Chem; 1995 Apr; 270(15):8712-22. PubMed ID: 7721776
[TBL] [Abstract][Full Text] [Related]
17. Purification, cDNA cloning, and expression of GDP-L-Fuc:Asn-linked GlcNAc alpha1,3-fucosyltransferase from mung beans.
Leiter H; Mucha J; Staudacher E; Grimm R; Glössl J; Altmann F
J Biol Chem; 1999 Jul; 274(31):21830-9. PubMed ID: 10419500
[TBL] [Abstract][Full Text] [Related]
18. Structure and mechanism of Helicobacter pylori fucosyltransferase. A basis for lipopolysaccharide variation and inhibitor design.
Sun HY; Lin SW; Ko TP; Pan JF; Liu CL; Lin CN; Wang AH; Lin CH
J Biol Chem; 2007 Mar; 282(13):9973-9982. PubMed ID: 17251184
[TBL] [Abstract][Full Text] [Related]
19. Solubilization and Iterative Saturation Mutagenesis of α1,3-fucosyltransferase from Helicobacter pylori to enhance its catalytic efficiency.
Choi YH; Kim JH; Park BS; Kim BG
Biotechnol Bioeng; 2016 Aug; 113(8):1666-75. PubMed ID: 26804479
[TBL] [Abstract][Full Text] [Related]
20. Donor substrate binding and enzymatic mechanism of human core α1,6-fucosyltransferase (FUT8).
Kötzler MP; Blank S; Bantleon FI; Spillner E; Meyer B
Biochim Biophys Acta; 2012 Dec; 1820(12):1915-25. PubMed ID: 22982178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
